Substituted pyrazoles as modulators of chemokine receptors

Details for Australian Patent Application No. 2006214453 (hide)

Owner Merck & Co., Inc.

Inventors Hutchinson, John; Vernier, Jean-Michel; Huang, Dehua; Cube, Rowena; Pinkerton, Anthony B.; Shen, Dong-Ming

Agent Spruson & Ferguson

Pub. Number AU-A-2006214453

PCT Pub. Number WO2006/088813

Priority 60/653,326 16.02.05 US; 60/660,364 10.03.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/088813 Priority application(s): WO2006/088813

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214454-Dosage form and method for sustained release of a substituted pyrazine compound

2006214444-Compositions and methods for detecting pathogen specific nucleic acids in urine